The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Hybridization-based target enrichment panel with our intrinsic probe design, rebalancing, and molecular barcode technologies to efficiently analyze not only hard-to-capture areas but also challenging samples, such as damaged DNA or RNA.
View Detail >
End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >
Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.
View Detail >
Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer.
View Detail >
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Explore the most up-to-date publications featuring Celemics’ products and services
View Detail >
Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science.
View Detail >
Explore a diverse range of engaging video content, from fascinating experiments showcasing cutting-edge research to heartfelt customer testimonials.
View Detail >
Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >
Let’s change the NGS market together – our global presence and partners world-wide
View Detail >
Waiting for your experience with Celemics, an innovative leader in NGS industry
View Detail >Agrigenomics
Journal Plantarum THE MOLECULAR AND PHYLOGENETIC CHARACTERIZATION OF THE TAGETES ERECTAL. AND COSMOS SULPHUREUSCAV. USING DNA BARCODING AND BIOINFORMATICS TECHNIQUES Abbas MA, Jahan S, Akram S, Fatima R. The molecular…
Journal of Gynecologic Oncology Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience Kim Y-N, Chung YS, Lee JH, Park E, Lee S-T,…
Journal of Clinical Medicine Genetic Characteristics of Patients with Young-Onset Myelodysplastic Neoplasms Kim H-Y, Yoo KH, Jung CW, Kim H-J, Kim S-H. Genetic characteristics of patients with young-onset myelodysplastic neoplasms.…
Blood Research TP53 mutation is a high-risk factor for Richter’s syndrome based on circulating tumor DNA Park HS, Son BR, Son SM, Kwon J. TP53 mutation is a high-risk factor…
Experimental & Molecular Medicine Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection Kim SY, Jeong S, Lee W, Jeon Y, Kim Y-J, Park S,…
Ann Lab Med Identification of potential genomic alterations using pan-cancer cell-free DNA next-generation sequencing in patients with gastric cancer Kim B, Kim Y, Cho JY, Lee K-A. Identification of potential…
Arch Endocrinol Metab Genetic diagnosis of congenital hypopituitarism in Turkish patients by a target gene panel: novel pathogenic variants in GHRHR, GLI2, LHX4 and POU1F1 genes Kırkgöz T, Gürsoy S,…
Korean Circulation Journal Clinical and Genetic Features of Korean Inherited Arrhythmia Probands Jeong JH, Oh S-K, Kim YG, Choi YY, Lee HS, Shim J, et al. Clinical and genetic features…
Ophthalmic Research Phenotypic and Genetic Alterations in Adult-Onset Cone and Cone-Rod Dystrophy Kim DJ, Woo SJ, Joo K. Phenotypic and genetic alterations in adult-onset cone and cone-rod dystrophy. Ophthalmic Res.…
Technology in Cancer Research & Treatment Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity Aktaş TÇ, Kızmazoğlu D, Aktaş S, Gökbayrak ÖE, Serinan E, Erol A,…
